Riskpilot← Back to searchSign inGet full accessNoctiluca Medicin AB
ABActiveOrg 5568708878Radiofyrsgatan 15Hospital activities · NACE 8610Est. 20111 employees
Revenue 2024
SEK 24K
-82% vs 2023
EBITDA margin
-404.2%
-385% vs 2023
Equity ratio
45.9%
Financial strength
Net profit 2024
SEK -97K
-385% vs 2023
| Revenue | SEK 24K | -82% |
| EBITDA | SEK -97K | -385% |
| Net profit | SEK -97K | -385% |
| Total assets | SEK 109K | -50% |
| Equity | SEK 50K | -66% |
| Employees | 1 | — |
Legal name
Noctiluca Medicin AB
Org number
5568708878
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
7 november 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukvård, undervisning och handledning inom anestesi, intensivvård samt primärvård och omhändertagande prehospitalt och i vildmark samt därmed förenlig verksamhet.
Address
Radiofyrsgatan 15
Phone
+46702283658
Email
erik926@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 63 | 178 | 139 | 133 | 24 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 12 | 130 | 35 | −20 | −97 |
| Depreciation & amort. | −0 | −6 | −6 | −0 | −0 |
| EBIT | 12 | 124 | 29 | −20 | −97 |
| Net financials | — | — | — | — | 1 |
| Profit before tax | 11 | 125 | 29 | −20 | −97 |
| Tax | −2 | −26 | −6 | −0 | −0 |
| Net profit | 9 | 99 | 23 | −20 | −97 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 162 | 319 | 236 | 218 | 109 |
| Equity | 144 | 243 | 191 | 147 | 50 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 18 | 76 | 45 | 71 | 59 |
| Total debt | 18 | 76 | 45 | 71 | 59 |
EBITDA margin
-404.2%
This company
15.8%
Market median
-2658% vs market
20202024
Equity ratio
45.9%
This company
38.2%
Market median
+20% vs market
20202024
Return on equity
-194.0%
This company
18.4%
Market median
-1154% vs market
20202024
Net profit margin
-404.2%
This company
8.1%
Market median
-5090% vs market
20202024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20202024
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EJ Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Noctiluca Medicin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Johan Olof Gustafsson | Chief Executive Officer | 0 companies |
| Lars-Olof Gustafsson | Deputy Board Member | 0 companies |